THE STATHAM GROVE SURGERY
STATHAM GROVE, STOKE NEWINGTON, LONDON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 10 | 15 | 66.7% | |
| HF 4 | 2011 | 14 | 16 | 87.5% | |
| HF 4 | 2012 | 20 | 23 | 87.0% | |
| HF 4 | 2013 | 18 | 20 | 90.0% | |
| HF004 | 2014 | 12 | 12 | 100.0% | |
| HF004 | 2015 | 13 | 14 | 92.9% | |
| HF004 | 2016 | 15 | 15 | 100.0% | |
| HF004 | 2017 | 18 | 18 | 100.0% | |
| HF004 | 2018 | 22 | 23 | 95.7% | |
| HF004 | 2019 | 20 | 20 | 100.0% | |
| HF004 | 2020 | 24 | 24 | 100.0% | |
| HF006 | 2021 | 26 | 29 | 89.7% | |
| HF006 | 2022 | 24 | 26 | 92.3% | |
| HF006 | 2023 | 25 | 25 | 100.0% |
